RFQ Attachment 6 - Questions and Answers Part 2.pdf
PDF 418 KB Posted
- Solicitation number
- RFQ-NIAID-24-2224314
About this file
This document is a set of Questions and Answers (Part 2) related to an RFQ (Request for Quotation) for Genomics Sequencing Services for the NIAID Centralized Sequencing Program. The RFQ solicitation number is RFQ-NIAID-24-2224314.
The key details are: NIAID is seeking commercially available clinical whole genome sequencing services, including interpretation and clinical reports, to support its clinical research. The services will be for a base period of 1 year with up to 4 option periods. The RFQ includes a detailed pricing template with various line items for different quantities of genome sequencing with 4-week turnaround. The RFQ provides responses to several questions about the pricing template, clarifying that the line items represent distinct option quantities for additional genome sequencings with interpretation and report. The North American Industry Classification System (NAICS) code is 541380 - Testing Laboratories and Services, and the solicitation is open competition without a small business set-aside.
View the file
Other files
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Genomics Sequencing Services for the NIAID Centralized Sequencing Program Notice ID: RFQ-NIAID-24-2224314
RFQ Attachment 6 – Questions & Answers Part 2
9/19/2024 – Amendment 3
With regard to the Quote Pricing Template:
Q1. Regarding Line# 1: “Base Quantity Genome Sequencing, 4-week turnaround time” – Is this Sequencing and return of RAW Data?
A1. Yes.
Q2. Lines 5–7: The Qty is the same (100) but identified as Option Quantity 3, Option Quantity 4 and Option Quantity 5. How are these items different?
A2. The type of work and the quantity on Line 5, Line 6, and Line 7 are not different. Lines 5-7 represent distinct option quantities for 100 additional genome sequencings with interpretation and report on each line. Among Lines 5-7, NIAID would have the option to exercise an additional 100, 200, or 300 genome sequencings with interpretation and report depending on how many of these options are required.
Q3. Lines 8-10: The Qty is the same (50) but identified as Option Quantity 6, Option Quantity 7 and Option Quantity 8. How are these items different?
A3. The type of work and the quantity on Line 8, Line 9, and Line 10 are not different. Lines 8-10 represent distinct option quantities for 50 additional genome sequencings with interpretation and report on each line. Among Lines 8-10, NIAID would have the option to exercise an additional 50, 100, or 150 genome sequencings with interpretation and report depending on how many of these options are required.
Q4. Lines 11-12: The Qty is the same (20) but identified as Option Quantity 9, Option Quantity 10 How are these items different?
A4. The type of work and the quantity on Line 11 and Line 12 are not different. Lines 11-12 represent distinct option quantities for 20 additional genome sequencings with interpretation and report on each line. Among Lines 11-12, NIAID would have the option to exercise an additional 20 or 40 genome sequencings with interpretation and report depending on how many of these options are required.
Q5. Lines 14-23: The Qty is the same (100) but identified as Option Quantity 12–21. This is the same as Lines 5–7. How are these items different?
A5. The type of work and the quantity on Lines 14-23 are not different from one another or Lines 5-
7. Lines 14-23 represent distinct option quantities for 100 additional genome sequencings with interpretation and report on each line. Among Lines 14-23, NIAID would have the option to exercise an additional 100, 200, 300, 400, 500, 600, 700, 800, 900, or 1000 genome sequencings with interpretation and report depending on how many of these options are required.
Q6. Line 24: The Qty is (50) but identified as Option Quantity 22, which is the same as Lines 8-10.
How is this item different?
A6. The type of work and the quantity on 24 are not different from Lines 8-10. Line 24 represents a distinct option quantity for 50 additional genome sequencings with interpretation and report.
With Line 24, NIAID would have the option to exercise an additional 50 genome sequencings with interpretation and report if this option is required.
File details come from the government source that posted it. Updated .